.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
McKesson
Fish and Richardson
Boehringer Ingelheim
Dow
Citi
Colorcon
McKinsey
Cantor Fitzgerald
Julphar

Generated: September 23, 2017

DrugPatentWatch Database Preview

THERMAZENE Drug Profile

« Back to Dashboard

What is the patent landscape for Thermazene, and what generic Thermazene alternatives are available?

Thermazene is a drug marketed by Thepharmanetwork Llc and is included in one NDA.

The generic ingredient in THERMAZENE is silver sulfadiazine. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.

Summary for Tradename: THERMAZENE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list13
Bulk Api Vendors: see list41
Patent Applications: see list4,562
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THERMAZENE at DailyMed

Pharmacology for Tradename: THERMAZENE

Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial
Applicant Tradename Generic Name Dosage NDA >Approval Date TE Type RLD RS Patent No. >Patent Expiration Product Substance Delist Req. >Exclusivity Expiration
Thepharmanetwork Llc
THERMAZENE
silver sulfadiazine
CREAM;TOPICAL018810-001Dec 23, 1985ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Harvard Business School
Dow
Novartis
Express Scripts
UBS
Healthtrust
Colorcon
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot